Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1024 of 5804
-
New hope for tough prostate cancer? drug combo enters early trial
Disease control Recruiting nowThis phase I/II tests the safety, side effects and best dose of ruxolitinib in combination with enzalutamide and how well it works in treating patients with prostate cancer that remains despite blocking hormone production (castration-resistant) and that has spread from where it f…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common diabetes drug help fight prostate cancer?
Disease control Not yet recruitingDapagliflozin is a well-established medication being marketed and used for treatment Type 2 diabetes mellitus (T2DM). In retrospective cohort studies done by our team, we found that metastatic prostate cancer patients who received Dapagliflozin together with standard anti-cancer …
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a simpler surgery be safer for aggressive uterine cancer?
Disease control Not yet recruitingThis study evaluates surgical strategies for treating patients with FIGO 2023 stage I and II high-risk endometrial cancer (EC) exhibiting p53 mutations. The trial aims to assess whether a less invasive sentinel lymph node (SLN) mapping approach provides non-inferior oncological o…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New prostate cancer radiation cuts sessions in half
Disease control Not yet recruitingThis is a single-arm, exploratory phase I clinical trial evaluating the safety and efficacy of ultra-hypofractionated carbon ion radiotherapy (CIRT) in 6 fractions compared to the conventional 12-fraction regimen in patients with low- and intermediate-risk localized prostate canc…
Phase: PHASE1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New heart implant aims to stop leaky valve symptoms
Disease control Not yet recruitingThe goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main ques…
Phase: NA • Sponsor: Polares Medical SA • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
CBD may cut opioid need in advanced prostate cancer
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the effects of cannabidiol in patients with end-stage metastatic castration-resistant prostate cancer (mCRPC). The primary objective is to determine whether cannabidiol (CBD) treatment can reduce the need for opioids in patients wit…
Phase: PHASE2 • Sponsor: Regionshospital Nordjylland • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Nasal spray may curb Post-Surgery confusion in seniors
Symptom relief Not yet recruitingThis clinical trial is designed to observe the effect of dexmedetomidine nasal spray on the incidence of postoperative delirium in elderly patients undergoing thoracoscopic lung resection. Eligible elderly patients scheduled for thoracoscopic lung resection will be randomly divid…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Timing of medical transport could save preemie brains: major french study launches
Knowledge-focused Not yet recruitingThe extremely preterm outborn births (delivered in maternity units without on-site neonatal intensive care) are associated with lower survival and increased risk of severe neurodevelopmental impairment compared with inborn births (delivered in maternity units with on-site neonata…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Can a drug curb Self-Harm? new trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial is to learn if naltrexone works to treat nonsuicidal self-injurious behavior in adolescents and adults.
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowIn this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to p…
Phase: PHASE2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New chemo cocktail aims to slow advanced colon cancer
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled, phase II study. It is expected to enroll 229 patients and aims to evaluate the efficacy and safety of FOLFOX8 versus mFOLFOX6 combined with bevacizumab or cetuximab as first-line treatment for unresectable metastatic colo…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to tackle tough bone cancer
Disease control Not yet recruitingThis is a single-center, single-arm, prospective observational study to evaluate the long-term local control rate, safety, and efficacy of preoperative neoadjuvant radiotherapy (36-45 Gy) followed by sequential radical surgery and postoperative chemotherapy in patients with high-…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a breast cancer drug treat ectopic pregnancy?
Disease control Not yet recruitingThe aim of work is to study the effectiveness of letrozole in treatment of early undisturbed ectopic pregnancy in comparison with Methotrexate.
Phase: PHASE2 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could stem cell secretions tame tough Crohn's? new trial aims to find out
Disease control Not yet recruitingThis research study is studying DB-3Q as a possible treatment for medically refractory Crohn's disease. The purpose of this study is to research and evaluate safety and effectiveness of the administration of bone marrow mesenchymal stem cell (bmMSC) derived extracellular vesicles…
Phase: PHASE2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Major study to uncover cancer Treatment's hidden toll on fertility
Knowledge-focused Not yet recruitingIn the past two decades, the evidence-based knowledge on the prevalence and risk factors for gonads impairment, including infertility, following cancer and numerous cancer treatment regimen has significantly increased. However, data remains mostly insufficient for individualized …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a common drug curb Self-Harm? new trial aims to find out
Disease control Not yet recruitingThis randomized, double-blinded, placebo-controlled clinical trial aims to evaluate the efficacy and safety of naltrexone in reducing nonsuicidal self-injurious behavior among individuals with nonsuicidal self-injury. Participants will be randomly assigned to receive either naltr…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for stomach cancer: drug cocktail targets tough cases
Disease control Not yet recruitingThe combination of immune checkpoint inhibitors and platinum containing dual drugs are more used as a first-line therapeutic approach for patients diagnosed with advanced gastric cancer for its superior efficacy. However, there are no standard recommendations for subsequent treat…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail of old drugs takes on advanced cancers
Disease control Recruiting nowThis is an open label phase II study using metronomic low-dose gemcitabine and mitomycin c given intravenously, and thalidomide administered orally, for patients with advanced solid tumors.
Phase: PHASE2 • Sponsor: Sarcoma Oncology Research Center, LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Herbal mix and cancer drug join forces to fight fluid in lungs
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether the Xuanyin Ning Formula combined with intrapleural injection of bevacizumab via chest tube drainage is effective in treating malignant pleural effusion. It will also evaluate the safety of this combination therapy. The main…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Robotic surgery gets a sense of touch for heart valve repair
Disease control Not yet recruitingThis study aims to test the safety and effectiveness of Force Feedback instruments used during robotic-assisted mitral valve repair with the da Vinci Surgical System, Model IS5000 (dV5).
Phase: NA • Sponsor: Intuitive Surgical • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC